Leptin decreases de novo lipogenesis in patients with lipodystrophy

34Citations
Citations of this article
36Readers
Mendeley users who have this article in their library.

Abstract

De novo lipogenesis (DNL) plays a role in the development of hepatic steatosis. In humans with lipodystrophy, reduced adipose tissue causes lower plasma leptin, insulin resistance, dyslipidemia, and ectopic triglyceride (TG) accumulation. We hypothesized that recombinant leptin (metreleptin) for 6 months in 11 patients with lipodystrophy would reduce DNL by decreasing insulin resistance and glycemia, thus reducing circulating TG and hepatic TG. The percentage of TG in TG-rich lipoprotein particle (TRLP-TG) derived from DNL (%DNL) was measured by deuterium incorporation from body water into palmitate. At baseline, DNL was elevated, similar to levels previously shown in obesity-associated nonalcoholic fatty liver disease (NAFLD). After metreleptin, DNL decreased into the normal range. Similarly, absolute DNL (TRLP-TG × %DNL) decreased by 88% to near-normal levels. Metreleptin improved peripheral insulin sensitivity (hyperinsulinemic-euglycemic clamp) and lowered hemoglobin A1c and hepatic TG. Both before and after metreleptin, DNL positively correlated with insulin resistance, insulin doses, and hepatic TG, supporting the hypothesis that hyperinsulinemia stimulates DNL and that elevated DNL is integral to the pathogenesis of lipodystrophy-associated NAFLD. These data suggest that leptin-mediated improvement in insulin sensitivity increases clearance of blood glucose by peripheral tissues, reduces hepatic carbohydrate flux, and lowers insulinemia, resulting in DNL reductions and improvements in hepatic steatosis and dyslipidemia.

References Powered by Scopus

Sources of fatty acids stored in liver and secreted via lipoproteins in patients with nonalcoholic fatty liver disease

2899Citations
N/AReaders
Get full text

Nonalcoholic Fatty Liver Disease: A Feature of the Metabolic Syndrome

2096Citations
N/AReaders
Get full text

Mechanisms of insulin action and insulin resistance

1823Citations
N/AReaders
Get full text

Cited by Powered by Scopus

Tissue-Specific Effects of Leptin on Glucose and Lipid Metabolism

137Citations
N/AReaders
Get full text

An adipocentric perspective on the development and progression of non-alcoholic fatty liver disease

90Citations
N/AReaders
Get full text

Unraveling the role of leptin in liver function and its relationship with liver diseases

72Citations
N/AReaders
Get full text

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Cite

CITATION STYLE

APA

Baykal, A. P., Parks, E. J., Shamburek, R., Syed-Abdul, M. M., Chacko, S., Cochran, E., … Brown, R. J. (2020). Leptin decreases de novo lipogenesis in patients with lipodystrophy. JCI Insight, 5(14). https://doi.org/10.1172/JCI.INSIGHT.137180

Readers over time

‘20‘21‘22‘23‘240481216

Readers' Seniority

Tooltip

PhD / Post grad / Masters / Doc 7

54%

Researcher 5

38%

Professor / Associate Prof. 1

8%

Readers' Discipline

Tooltip

Medicine and Dentistry 8

62%

Biochemistry, Genetics and Molecular Bi... 3

23%

Computer Science 1

8%

Nursing and Health Professions 1

8%

Article Metrics

Tooltip
Social Media
Shares, Likes & Comments: 41

Save time finding and organizing research with Mendeley

Sign up for free
0